EGEN

COM:EGENESISBIO

eGenesis

  • Privately Held

eGenesis is revolutionizing the field of transplantation with a multiplexed gene editing platform for the development of human-compatible organs, tissues, and cells. The company is focused on solving the global organ shortage crisis by developing a scalable alternative to allotransplantation and reinvigorating the field of xenotransplantation.

peer of

competitor of